![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PFIZER CUTS THE PRICE OF SOME DRUGS IN SWITZERLAND
PFIZER CUTS THE PRICE OF SOME DRUGS IN SWITZERLAND
July 3, 2006
Pfizer Inc. (PFE) Monday said it plans to lower the price of some of its drugs, including hypertension drug Norvasc, and other medicines that lost patent protection in Switzerland.
Market
Watch
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct